company

ASLAUG ANDERSENS FOND TIL REUMATOLOGISK FORSKNING I BERGEN

5021 BERGEN

Return on Equity
−4,5 %
Current Ratio
334,13
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue26 000
Net Income−129 000
Total Assets2 874 000
Total Equity2 866 000
Income (NOK)2022
Revenue26 000
Expenditure155 000
Operating Profit−129 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−129 000
Tax0
Net Income−129 000
Balance (NOK)2022
Total Fixed Assets200 000
Total Current Assets2 673 000
Total Assets2 874 000
Total Retained Equity1 366 000
Total Equity2 866 000
Total Long-Term Debt0
Total Current Debt8 000
Total Equity and Debt2 874 000
Cash flow (NOK)2022
Sales Income0
Other Income26 000
Revenue26 000
Cost of Goods Sold0
Salary Costs14 000
Depreciation0
Impairment0
Expenditure155 000
Operating Profit−129 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−129 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets200 000
Total Fixed Assets200 000
Stock0
Total Investments0
Cash, Bank2 673 000
Total Current Assets2 673 000
Total Assets2 874 000
Total Equity2 866 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt8 000
Total Current Debt8 000
Total Equity and Debt2 874 000
Financial indicators2022
Return on Equity−4,5 %
Debt-to-Equity Ratio0
Operating Profit Margin−496,15 %
Current Ratio334,13
Quick Ratio334,13
Equity Ratio1
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English